Aerospace and defense company Ducommun (NYSE: DCO) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 11.8% year on year to $224.5 million. Its non-GAAP profit of $1.18 per share was 20.2% above analysts’ consensus estimates.

Is now the time to buy DCO? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Ducommun’s second quarter was marked by strong demand across its core aerospace and defense markets, resulting in financial results that exceeded Wall Street expectations and a positive market reaction. Management attributed this performance to continued execution of its VISION 2027 strategy, with particular emphasis on expanding engineered product content, capitalizing on commercial aerospace recovery, and robust growth in missile programs. CEO Stephen Oswald highlighted that a 68% increase in missile-related sales and new aftermarket retrofit orders for the 737 MAX platform were major contributors to quarterly momentum.

Looking ahead, Ducommun’s outlook is shaped by anticipated growth in missile production, ongoing demand for engineered products, and further progress in its commercial aerospace business. Management believes the company is well positioned to benefit from long-term defense contracts, recent framework agreements with major defense primes, and incremental content on key aircraft platforms. CFO Suman Mookerji emphasized that the company is maintaining investments in capacity and hiring to support these trends, while also monitoring supply chain risks and the timing of new orders.

Key Insights from Management’s Remarks

Management pointed to engineered product mix expansion, missile demand, and aftermarket wins as the most impactful drivers of the quarter’s outperformance and set the stage for future growth.

• Missile program momentum: Missile-related sales surged 68% year over year, led by the PAC-3 program with Lockheed Martin. Management stated that strong replenishment orders, combined with Ducommun’s established supplier position, were pivotal to this growth.
• Aftermarket 737 MAX win: The company secured a large retrofit order for engineered switches on the Boeing 737 MAX, an incremental win expected to generate recurring revenue through both ongoing retrofits and future line-fit opportunities.
• Engineered products mix shift: The proportion of revenue from engineered products increased to 23%, up from 15% in 2022. Management described this as the centerpiece of its value creation plan, supporting higher margins and greater pricing power.
• Facility consolidation benefits: Cost savings from facility consolidation initiatives have reached their expected annual run rate, supporting margin expansion as manufacturing volumes increase.
• Backlog and book-to-bill strength: Remaining performance obligations grew to $1.16 billion, with a quarterly book-to-bill ratio of 1.4x. Management highlighted this as evidence of robust demand and improved visibility into future revenue streams.

Drivers of Future Performance

Ducommun’s forward outlook is driven by missile program ramps, continued engineered product growth, and sustained momentum in commercial aerospace, balanced by headwinds from lingering destocking and timing of new orders.

• Missile production ramp: Management expects significant increases in missile production volumes as new multi-year framework agreements with defense primes translate into orders, particularly for programs like PAC-3, Tomahawk, and Standard Missile platforms.
• Engineered product focus: Shifting the business mix toward proprietary engineered products is a key strategic priority, with management anticipating ongoing margin improvement and differentiated revenue streams as this transition continues through both organic growth and targeted M&A.
• Commercial aerospace recovery: While commercial aerospace demand is recovering, management cautioned that destocking headwinds may persist through year-end. However, higher OEM build rates, new retrofit opportunities, and easing supply chain constraints are expected to support mid- to high-single digit revenue growth in the segment over the next year.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be closely watching (1) the pace at which missile program ramps and new framework agreements convert into firm orders, (2) the continued expansion of engineered product content and associated margin improvement, and (3) signs of sustained commercial aerospace recovery in light of ongoing destocking and supply chain normalization. Execution on the M&A front and progress toward VISION 2027 milestones will also be key areas of focus.

Ducommun currently trades at $201.44, up from $191.68 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.